What is ABVC stock price today?

ABVC (Abvc Biopharma Inc) stock is trading at $2.15 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is ABVC stock going up or down today?

ABVC stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ABVC stock now?

The decision to buy ABVC depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ABVC a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ABVC based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ABVC stock overvalued or undervalued?

Use our DCF valuation calculator to determine if ABVC is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is ABVC's P/E ratio?

P/E ratio data for ABVC will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is ABVC's market cap?

ABVC (Abvc Biopharma Inc) has a market capitalization of $0.05 billion, making it a small-cap stock.

What is ABVC's price to book ratio?

ABVC trades at a price-to-book (P/B) ratio of 4.07, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does ABVC pay dividends?

ABVC does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is ABVC's dividend yield?

ABVC does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is ABVC stock a good long-term investment?

ABVC's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ABVC's revenue growth rate?

ABVC has shown revenue growth of 1.0% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Profitability metrics for ABVC are available on our dashboard with complete income statement analysis.

What are the risks of investing in ABVC?

Key risks for ABVC include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ABVC compare to its competitors?

Compare ABVC to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ABVC's performance and positioning.

What is ABVC's stock price target for 2026?

Our AI model provides price targets for ABVC based on fundamental analysis: Bull case $2.79 (+30%), Base case $2.47 (+15%), Bear case $1.94 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about ABVC?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ABVC. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ABVC's next earnings report?

ABVC reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ABVC - Abvc Biopharma Inc

NYSE * Health Care * Biotechnology

$2.15

+$0.13 (+6.44%)

About Abvc Biopharma Inc

ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials as a combination therapy for triple negative breast cancer; ABV-1504, which has completed Phase II clinical trials for depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1702, which is in Phase II clinical trials to treat myelodysplastic syndromes; and ABV-1601, which is in Phase I/II clinical trials for treating depression in cancer patients. It is also developing ABV-1701 Vitargus, which is in Phase II clinical trials for the treatment of retinal detachment or vitreous hemorrhage; ABV-1519, which is in Phase I/II clinical trials for the treatment of non-small cell lung cancer; ABV-2001, an intraocular irrigation solution; ABV-2002, a corneal Storage Solution; and ABV-1703, which is in Phase II clinical trials for the treatment of metastatic pancreatic cancer. ABVC BioPharma, Inc. has a co-development agreement with Rgene Corporation and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California. ABVC BioPharma, Inc. operates as a subsidiary of YuanGene Corporation.

ABVC Key Statistics

Market Cap

$49.09M

P/B Ratio

4.07

EPS

$-0.28

Revenue Growth

+1.0%

Employees

How ABVC Compares to Peers

ABVC has the fastest revenue growth among competitors

ABVC is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
ABVC(This stock)	$49.09M	N/A	1%	0.0%	-
AMGNAmgen Inc	$177.92B	25.6	0%	0.2%	vs AMGN
GILDGilead Sciences	$154.99B	19.3	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$113.16B	31.1	0%	0.3%	vs VRTX
REGNRegeneron Pharmaceuticals	$77.69B	17.6	0%	0.3%	vs REGN
BIIBBiogen Inc	$24.26B	15.1	0%	0.2%	vs BIIB

Abvc Biopharma Inc Company Information

Headquarters: California; U.S.A
Website: www.abvcpharma.com
Sector: Health Care
Industry: Biotechnology

ABVC - Abvc Biopharma Inc

About Abvc Biopharma Inc

ABVC Key Statistics

How ABVC Compares to Peers

Abvc Biopharma Inc Company Information

ABVC Lician Score

ABVC Financial Snowflake

Upcoming Events for ABVC